The price of insulin and other lifesaving prescription drugs are increasingly more expensive. In response, the Democrats’ so-called “Inflation Reduction Act” imposed a $35 monthly out-of-pocket price ceiling on insulin for Medicare recipients. But does this actually address the reason why these drugs are so expensive, or are they missing the mark? On this episode, we expose the root cause of the high cost of insulin (and other life-saving prescription drugs), and what must happen to ensure these prices are affordable and treatment options are abundant.